Hemodynamic effects of prostaglandin E1 infusion in patients with acute myocardial infarction and left ventricular failure
dc.contributor.author | Popat, Kishor D. | en_US |
dc.contributor.author | Pitt, Bertram | en_US |
dc.date.accessioned | 2006-04-07T17:53:27Z | |
dc.date.available | 2006-04-07T17:53:27Z | |
dc.date.issued | 1982-04 | en_US |
dc.identifier.citation | Popat, Kishor D., Pitt, Bertram (1982/04)."Hemodynamic effects of prostaglandin E1 infusion in patients with acute myocardial infarction and left ventricular failure." American Heart Journal 103(4, Part 1): 485-489. <http://hdl.handle.net/2027.42/24025> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6W9H-4BT99YV-N4/2/de0fa3682dc980268857d2a9c54e0798 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/24025 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=7199815&dopt=citation | en_US |
dc.description.abstract | Prostaglandin E1 (PGE1) has been shown to limit infarct size, improve coronary blood flow, inhibit platelet aggregation, and reduce both left ventricular (LV) preload and afterload in experimental animals. Its use in the therapy of patients with acute myocardial infarction (AMI) and congestive heart failure (CHF) has not, however, been reported. Five patients with AMI of less than 12 hours' duration and LV dysfunction were studied to assess the hemodynamic effects of IV infusion of PGE1. PGE1 in the concentration of 0.4 [mu]g/ml was infused at a rate of 0.003 [mu]g/kg/min (3 ng [middle dot] kg-1 [middle dot] min-1) to a maximum rate of 0.021 [mu]g/kg/min (21 ng [middle dot] kg-1 [middle dot] min-1) for a total time of up to 90 minutes. There was an insignificant increase in heart rate, with significant decreases in mean arterial blood pressure and systemic vascular resistance. Pulmonary capillary wedge pressure declined from 21 +/- 3 to 15 +/- 1 mm Hg (p p 2 (p p 1 infusion. One patient had transient nausea which did not require discontinuation of the drug. PGE1 is an effective vasodilator and deserves further application in therapy for AMI patients with CHF. | en_US |
dc.format.extent | 576521 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Hemodynamic effects of prostaglandin E1 infusion in patients with acute myocardial infarction and left ventricular failure | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Division of Cardiology, Department of Internal Medicine, University of Michigan Medical Center, University Hospital, Ann Arbor, Mich., USA. | en_US |
dc.contributor.affiliationum | Division of Cardiology, Department of Internal Medicine, University of Michigan Medical Center, University Hospital, Ann Arbor, Mich., USA. | en_US |
dc.identifier.pmid | 7199815 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/24025/1/0000274.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0002-8703(82)90334-9 | en_US |
dc.identifier.source | American Heart Journal | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.